78 related articles for article (PubMed ID: 12213859)
41. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
[TBL] [Abstract][Full Text] [Related]
42. Long-term outcome of patients with insular carcinoma of the thyroid: the insular histotype is an independent predictor of poor prognosis.
Pellegriti G; Giuffrida D; Scollo C; Vigneri R; Regalbuto C; Squatrito S; Belfiore A
Cancer; 2002 Nov; 95(10):2076-85. PubMed ID: 12412160
[TBL] [Abstract][Full Text] [Related]
43. Papillary thyroid carcinoma: factors influencing recurrence and survival.
Toniato A; Boschin I; Casara D; Mazzarotto R; Rubello D; Pelizzo M
Ann Surg Oncol; 2008 May; 15(5):1518-22. PubMed ID: 18324441
[TBL] [Abstract][Full Text] [Related]
44. Pure versus follicular variant of papillary thyroid carcinoma: clinical features, prognostic factors, treatment, and survival.
Zidan J; Karen D; Stein M; Rosenblatt E; Basher W; Kuten A
Cancer; 2003 Mar; 97(5):1181-5. PubMed ID: 12599223
[TBL] [Abstract][Full Text] [Related]
45. Distant metastases in papillary thyroid carcinoma: 100 cases observed at one institution during 5 decades.
Dinneen SF; Valimaki MJ; Bergstralh EJ; Goellner JR; Gorman CA; Hay ID
J Clin Endocrinol Metab; 1995 Jul; 80(7):2041-5. PubMed ID: 7608252
[TBL] [Abstract][Full Text] [Related]
46. Completion thyroidectomy in 131 patients with differentiated thyroid carcinoma.
Scheumann GF; Seeliger H; Musholt TJ; Gimm O; Wegener G; Dralle H; Hundeshagen H; Pichlmayr R
Eur J Surg; 1996 Sep; 162(9):677-84. PubMed ID: 8908447
[TBL] [Abstract][Full Text] [Related]
47. Prognostic factors in well-differentiated thyroid carcinoma.
Cushing SL; Palme CE; Audet N; Eski S; Walfish PG; Freeman JL
Laryngoscope; 2004 Dec; 114(12):2110-5. PubMed ID: 15564829
[TBL] [Abstract][Full Text] [Related]
48. [Thyroid cancers].
Mogoş V; Zbranca E; Strat V; Diaconescu MR; Chifan M; Florea N; Costăchescu G; Găleşanu MR; Rusu V; Georgescu G
Rev Med Chir Soc Med Nat Iasi; 1995; 99(1-2):72-81. PubMed ID: 9524659
[TBL] [Abstract][Full Text] [Related]
49. [Therapeutic concepts and long-term outcome in thyroid gland carcinoma].
Linder R; Fuhrmann J; Hammerschmidt D
Zentralbl Chir; 1996; 121(6):459-64. PubMed ID: 8767331
[TBL] [Abstract][Full Text] [Related]
50. Tall cell variant of papillary thyroid carcinoma: a population-based study in Iceland.
Axelsson TA; Hrafnkelsson J; Olafsdottir EJ; Jonasson JG
Thyroid; 2015 Feb; 25(2):216-20. PubMed ID: 25322334
[TBL] [Abstract][Full Text] [Related]
51. [Papillary carcinoma of the thyroid. A uni- and multivariate analysis of the factors affecting the prognosis inclusive of surgical treatment].
Pelizzo MR; Toniato A; Grigoletto R; Bernardi C; Pagetta C
Minerva Chir; 1998 Jun; 53(6):471-82. PubMed ID: 9774838
[TBL] [Abstract][Full Text] [Related]
52. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
53. Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases.
Samaan NA; Maheshwari YK; Nader S; Hill CS; Schultz PN; Haynie TP; Hickey RC; Clark RL; Goepfert H; Ibanez ML; Litton CE
J Clin Endocrinol Metab; 1983 Jun; 56(6):1131-8. PubMed ID: 6841555
[TBL] [Abstract][Full Text] [Related]
54. [Significance of lymph node metastases of differentiated thyroid gland carcinomas and C-cell carcinomas for prognosis--a meta-analysis].
Witte J; Schlotmann U; Simon D; Dotzenrath C; Ohmann C; Goretzki PE
Zentralbl Chir; 1997; 122(4):259-65. PubMed ID: 9221636
[TBL] [Abstract][Full Text] [Related]
55. [Loco-regional persistence and recurrences of operated differentiated thyroid cancers. 22 cases on 589 treated patients from 1964 to 1990, follow-up from 5 to 31 years].
Proye C; Gontier A; Capuano G; Combemale F; Carnaille B; Decoulx M; Wemeau JL; Lecomte-Houcke M
Ann Endocrinol (Paris); 1997; 58(3):233-9; discussion 240-1. PubMed ID: 9239247
[TBL] [Abstract][Full Text] [Related]
56. Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma.
Kashima K; Yokoyama S; Noguchi S; Murakami N; Yamashita H; Watanabe S; Uchino S; Toda M; Sasaki A; Daa T; Nakayama I
Thyroid; 1998 Mar; 8(3):197-202. PubMed ID: 9545105
[TBL] [Abstract][Full Text] [Related]
57. Incidence and Risk Factors of Thyroid Malignancy in Patients with Toxic Nodular Goiter.
Mohamed TZ; Sultan AAEA; Tag El-Din M; Mostafa AAE; Nafea MA; Kalmoush AE; Nassar MS; Abdalgaleel MA; Hegab AM; Ibrahim AH; Baheeg M
Int J Surg Oncol; 2022; 2022():1054297. PubMed ID: 35656410
[TBL] [Abstract][Full Text] [Related]
58. Malignancy risk of hyperfunctioning thyroid nodules compared with non-toxic nodules: systematic review and a meta-analysis.
Lau LW; Ghaznavi S; Frolkis AD; Stephenson A; Robertson HL; Rabi DM; Paschke R
Thyroid Res; 2021 Feb; 14(1):3. PubMed ID: 33632297
[TBL] [Abstract][Full Text] [Related]
59. Hyperfunctioning thyroid carcinoma: A systematic review.
Liu J; Wang Y; Da D; Zheng M
Mol Clin Oncol; 2019 Dec; 11(6):535-550. PubMed ID: 31798874
[TBL] [Abstract][Full Text] [Related]
60. Concurrent hyperthyroidism and papillary thyroid cancer: a fortuitous and ambiguous case report from a resource-poor setting.
Kadia BM; Dimala CA; Bechem NN; Aroke D
BMC Res Notes; 2016 Jul; 9():369. PubMed ID: 27461263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
